Analysts think IPSC stock price could increase by 392%
Jul 27, 2024, 6:26 AM
-28.51%
What does IPSC do
Century Therapeutics, headquartered in Philadelphia, specializes in developing off-the-shelf allogeneic cell therapies for cancer, utilizing an advanced platform featuring iPSCs and CRISPR technology. Their key products, including CNTY-101 and CNTY-102, target B-cell lymphoma, with other candidates aimed at solid tumors and leukemia.
7 analysts think IPSC stock price will increase by 391.57%. The current median analyst target is $12.24 compared to a current stock price of $2.49. The lowest analysts target is $11.11 and the highest analyst target is $17.85.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.